PIP Framework Partnership Contribution Questionnaire 2026

Introduction to the Pandemic Influenza Preparedness Framework (PIP Framework) Partnership Contribution (PC) Questionnaire - 2026

Note for Respondents to the 2026 PIP Framework PC Questionnaire: 

We are requesting all respondents to complete the Questionnaire in full, regardless of whether they have completed the Questionnaire in previous years. Thank you in advance for your cooperation.

Purpose

This questionnaire helps WHO to better understand who is using GISRS and for what purposes. This, in turn, allows WHO to identify contributors under the PIP Partnership Contribution. For a short video in English on the PIP Partnership Contribution, please click here. To see the video in other languages, please click here.

Contributor identification

Under the PIP Framework a contributor is considered to be a company/institution that:

• is an influenza vaccine, diagnostic or pharmaceutical manufacturer, as defined in PIP Framework, Section 4.3 (currently or in the past 15 years); and
• uses (or has used in the past 15 years) the WHO Global Influenza Surveillance and Response System (GISRS).

"Use of GISRS" means your company/institution used or received:

• materials (e.g. virus materials, such as candidate vaccine viruses, wild-type viruses, cDNA, plasmids, or reagents); or
• services (e.g. antigenic and genetic characterization of candidate vaccine viruses/seed material, antiviral susceptibility assays); or
• information (e.g. sequence information, epidemiological data, antiviral susceptibility data, pre- and post-vaccine composition meeting reports) developed or provided by or through GISRS.

If your company/institution is identified as a contributor to the PIP Partnership Contribution based on your responses to this quesionnaire, you will be contacted by WHO. More information on the collection process is available at the PIP Partnership Contribution home page.